Perioperative Continuation of Metformin Therapy in Patients With Typ 2 Diabetes Mellitus Undergoing Non-cardiac Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

Also called NCT04284722

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Kepler University Hospital (from the registry)
Registry
  • NCT NCT04284722
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04284722. Randomized; no masking; primary purpose prevention. Start 2020-02 (anticipated); primary completion 2021-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Perioperative Continuation of Metformin Therapy in Patients With Typ 2 Diabetes Mellitus Undergoing Non-cardiac Surgery
Condition
Hyperglycemia
Condition
Metformin
Condition
Hyperlactatemia
Intervention (Drug)
Metformin Hydrochloride
Lead sponsor
Kepler University Hospital (class: other)

Record details

Record id
cardio:ct-nct04284722
Content hash
a8ad6c15a4414d7fe5ee100b717dd5763ca2ef8cfc2e5e705acab69abeebed19